Archive: May 2026
Feature
A Review of Therapies for Primary Biliary Cholangitis
Abstract: Primary biliary cholangitis (PBC) is a rare, chronic, progressive autoimmune cholestatic liver disease that can lead to cirrhosis if left untreated. Ursodeoxycholic acid remains the […]
Case Study Series
Connecting the Dots Between Theory and Practice: Speaking With Your Patients About IBS-C Management
About the Patient MB is a 32-year-old woman with symptoms of constipation dating back to college. She notes that these symptoms have worsened over the past […]
Letter From the Editor
Letter From the Editor: Exploring the Disease Entity of MetALD
In 2023, MetALD was officially introduced as a disease entity, as part of a broader international, multisociety consensus process. MetALD is a new medical classification for […]
Advances in IBD
JAK Inhibitor–Associated Acne in IBD: Recognition and Management
G&H How often does acne develop in inflammatory bowel disease patients treated with Janus kinase inhibitors? BC Acne is most commonly associated with the Janus kinase […]
MASH in Focus
Highlights From the Recent AASLD Guidance on MASLD/MASH in Children
G&H Why was there a need to develop separate practice guidance for pediatric metabolic dysfunction-associated steatotic liver disease? SX In 2023, when the American Association for […]
Advances in Hepatology
How to Identify and Treat MetALD
G&H Why was new nomenclature created recently to describe metabolic dysfunction-associated steatotic liver disease and increased alcohol intake, or MetALD? PK A multinational, multisociety consensus process […]
Advances in IBS
How AI Will Transform the Care of Patients With DGBIs
G&H In what ways is artificial intelligence transforming the care of patients with disorders of gut-brain interaction? BS In this era of data analytics and artificial […]